ESR1 and neoplasm: Two transcription factors of this family present in our array, NFκB2 and RELB, showed over-expression in ESR1-negative BRCA1 tumours with fold changes relative to ESR1-positive tumours ranging from 3.7 to 4.1, respectively (two-tailed t-test P-values <0.05.